Computer Implemented Modular Based Medical Market Analysis System

• US 20110093280A1
• Filed: 10/20/2009
• Published: 04/21/2011
• Est. Priority Date: 10/20/2009
• Status: Abandoned Application

• Current Assignee: The Arcas Group, LLC
• Original Assignee: The Arcas Group, LLC
• Inventors: Heybroek, Jan Andre
• Application Number:
  US12/582,056
• Publication Number:
  US 20110093280A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 40/20 for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

Abstract

Disclosed is an online computerized disease intelligence platform for use in medical market analysis. The system provides a physician'"'"'s view of the medical market and disease landscape using physician interaction and real-time data feeds. Furthermore, the system identifies and uses expert thought leader physicians in analyzing treatment protocols and trends in providing reports to users of the platform. The system further graphically maps physician influences and identified thought leaders in therapy areas.

Claims

1. A computer implemented modular based medical market analysis system comprising:

identifying at least one thought leader physician for a targeted therapy area;

providing a patient treatment protocol reported by the thought leader;

graphically representing an influence of the thought leader related to other physicians.

2. The medical market analysis system of claim 1, further including providing a professional profile of the thought leader physician including publications and clinical trials related to the thought leader physician in real time.

3. The medical market analysis system of claim 2, further including updating in real-time the provided publications and clinical trials wherein available hyper links to each clinical trial and publication are provided.

4. The medical market analysis system of claim 1, wherein the graphically represented thought leader'"'"'s influence includes graphically representing the thought leader'"'"'s influence to one or more additional thought leaders, wherein the additional thought leaders select the thought leader physician.

5. The medical market analysis system of claim 1, wherein the graphically represented thought leader'"'"'s influence includes graphically representing the thought leader'"'"'s influence to one or more additional thought leaders, wherein the additional thought leaders are selected by the thought leader physician.

6. The medical market analysis system of claim 1, wherein the influence of the thought leader physician is graphically represented on a national geographical area a local geographic area and a patient referral basis.

7. The medical market analysis system of claim 5, wherein the local geographic area is selected from the group consisting of cities, counties, states and combinations thereof.

8. The medical market analysis system of claim 1, wherein the graphically represented thought leader'"'"'s influence includes graphically representing the thought leader'"'"'s influence to one or more physicians not chosen as thought leaders, wherein the physicians not chosen as thought leaders select the thought leader physician.

9. The medical market analysis system of claim 1, wherein the graphically represented thought leader'"'"'s influence includes graphically representing a target physician and the target physician'"'"'s relationship to the thought leader physician.

10. The medical market analysis system of claim 1, wherein the influence of the thought leader physician is graphically represented on a referral network of physicians.

11. The medical market analysis system of claim 1, wherein the graphically represented thought leader'"'"'s influence includes providing a hyperlinked profile of a graphically represented physician.

12. The medical market analysis system of claim 1, wherein indentifying the thought leader physician includes physicians selecting the thought leader physician.

13. The medical market analysis system of claim 1, further including ranking the thought leader physicians relative to each other.

14. A computer implemented modular based real-time medical market analysis system comprising:

providing a physician and thought leader module including displaying physician and thought leader profiles and displaying a treatment protocol report;

providing a clinical intelligence module including displaying a treatment log report; and

providing an analysis module including displaying insight reports providing analysis of treatment decisions by thought leader physicians.

15. The medical market analysis system of claim 14, wherein the physician and thought leader module further including graphically representing an influence of a thought leader physician related to other physicians.

16. The medical market analysis system of claim 15, wherein the graphically represented thought leader'"'"'s influence includes graphically representing the thought leader'"'"'s influence to one or more physicians not chosen as thought leaders, wherein the physicians not chosen as thought leaders select the thought leader physician.

17. The medical market analysis system of claim 16, wherein the graphically represented thought leader'"'"'s influence includes graphically representing the thought leader'"'"'s influence to one or more additional thought leaders, wherein the additional thought leaders select the thought leader physician and graphically representing the thought leader'"'"'s influence wherein the additional thought leaders are selected by the thought leader physician.

18. The medical market analysis system of claim 15, wherein the influence of the thought leader physician is graphically represented on a national geographical area and a local geographic area basis.

19. The medical market analysis system of claim 14, wherein the displayed treatment protocol report is comprised of an aggregation of treatment profiles.

20. The medical market analysis system of claim 19, wherein the treatment profiles are electronically collected from electronic physician surveys.

21. The medical market analysis system of claim 14, wherein the displayed treatment log report comprises an aggregate of collected clinician treatment logs comprised of physician treatment decisions.

22. The medical market analysis system of claim 21, wherein the clinician treatment log includes an electronic form wherein the clinical treatment decisions are entered.

23. The medical market analysis system of claim 21, wherein the treatment log report is a combination of treatment logs aggregated and analyzed for an interval of time.

24. The medical market analysis system of claim 23, wherein the interval of time is a month and the treatment log report is displayed as a monthly report with a trailing monthly view.

25. The medical market analysis system of claim 14, wherein the displayed insight reports are further selected from the group consisting essentially of market trend reports, customized market reports based upon physician survey and combinations thereof.

26. The medical market analysis system of claim 14, further including providing a user access limited to at least two of the three modules.

27. The medical market analysis system of claim 14, further including providing supplemental information modules selected from the group consisting essentially of trial site profiling, institution clinical trial analysis, field activity tracking systems and combinations thereof.

28. The medical analysis system of claim 27, wherein the trial site profiling module includes displaying general site information and hyperlinks to affiliated investigator profiles.

29. The medical analysis system of claim 27, wherein the field activity tracking systems module includes field uploaded data supplements providing prefilled intelligence wherein validated customer relationship management resources.

30. A computer implemented modular based real-time medical market analysis system comprising:

providing a physician and thought leader module including displaying physician and thought lead profiles and displaying a treatment protocol report wherein the displayed treatment protocol report is comprised of an aggregation of treatment profiles and graphically representing an influence of a thought leader physician related to other physicians;

providing a clinical intelligence module including displaying a treatment log report, wherein the treatment log report comprises an aggregate of collected clinician treatment logs comprised of physician treatment decisions, wherein the clinician treatment log is an electronic form wherein the clinical treatment decisions are entered; and

providing an analysis module including displaying insight reports providing analysis of treatment decisions by thought leader physicians.

31. The medical market analysis system of claim 30, wherein the clinician treatment log is an electronic form wherein the clinical treatment decisions are entered.

32. The medical market analysis system of claim 30, wherein the treatment log report is a combination of treatment logs aggregated and analyzed for an interval of time.

33. The medical market analysis system of claim 32, wherein the interval of time is a month and the treatment log report is displayed as a monthly report with a trailing monthly view.

34. The medical market analysis system of claim 30, wherein the displayed insight reports are further selected from the group consisting essentially of market trend reports, customized market reports based upon physician survey and combinations thereof.

35. The medical market analysis system of claim 30, further including providing a user access limited to at least two of the three modules.

36. The medical market analysis system of claim 30, further including providing supplemental information modules selected from the group consisting essentially of trial site profiling, institution clinical trial analysis, field activity tracking systems and combinations thereof.

37. The medical analysis system of claim 36, wherein the field activity tracking systems module includes field uploaded data supplements providing prefilled intelligence forms with validated customer relationship management resources.

38. The medical market analysis system of claim 30, further including providing a professional profile of the thought leader physician including publications and clinical trials related to the thought leader physician and providing a profile of an institution.

39. The medical market analysis system of claim 30, further including updating in real-time the provided publications and clinical trials wherein available hyper links to each clinical trial and publication are provided.

40. The medical market analysis system of claim 30, wherein the graphically represented thought leader'"'"'s influence includes graphically representing the thought leader'"'"'s influence to one or more additional thought leaders, wherein the additional thought leaders select the thought leader physician.